drugset / Trial / NCT00986531
The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics
RandomizedCrossoverDouble-blindBasic science
Summary
The purpose of this study is to assess if AZD8529 improves performance on neurobehavioral probes of attention, working memory and affective reactivity in patients with schizophrenia.
Timeline
- Start
- 2009-11
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8529 | Other / unclassified | 80 mg | Oral |